Drugs / Levodopa/carbidopa
last change Feb 2013 re-read 3 minutes ago

Levodopa/carbidopa

Developed for
Parkinson disease
Investigated by
NeuroDerm Ltd.

Trials 1

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01725802 Dec 2012 → Feb 2013 Parkinson disease NeuroDerm Ltd. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Levodopa/carbidopa ClinicalTrials.gov intervention name — accepted as the source's own label NCT01725802 ↗